These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23537719)

  • 21. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk.
    Kothary N; Weintraub JL; Susman J; Rundback JH
    J Vasc Interv Radiol; 2007 Dec; 18(12):1517-26; quiz 1527. PubMed ID: 18057286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
    Larson AC; Wang D; Atassi B; Sato KT; Ryu RK; Lewandowski RJ; Nemcek AA; Mulcahy MF; Kulik LM; Miller FH; Salem R; Omary RA
    Radiology; 2008 Mar; 246(3):964-71. PubMed ID: 18309018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma.
    Wang D; Gaba RC; Jin B; Riaz A; Lewandowski RJ; Ryu RK; Sato KT; Ragin AB; Kulik LM; Mulcahy MF; Salem R; Larson AC; Omary RA
    Acad Radiol; 2011 Jul; 18(7):828-36. PubMed ID: 21669349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoembolization for the treatment of large hepatocellular carcinoma.
    Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Sugimori N; Igarashi S; Nakashima Y; Notsumata K; Toya D; Tanaka N; Mitsui T; Matsui O
    J Vasc Interv Radiol; 2010 Aug; 21(8):1226-34. PubMed ID: 20598571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter arterial chemoembolization for hepatocellular carcinoma fed by the reconstructed inferior phrenic artery: anatomical and technical analysis.
    Miyayama S; Matsui O; Taki K; Minami T; Ito C; Shinmura R; Takamatsu S; Kobayashi M; Notsumata K; Toya D; Tanaka N; Kozaka K
    J Vasc Interv Radiol; 2004 Aug; 15(8):815-23. PubMed ID: 15297585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas.
    Golfieri R; Cappelli A; Cucchetti A; Piscaglia F; Carpenzano M; Peri E; Ravaioli M; D'Errico-Grigioni A; Pinna AD; Bolondi L
    Hepatology; 2011 May; 53(5):1580-9. PubMed ID: 21351114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization.
    Dong S; Ye XD; Yuan Z; Xu LC; Xiao XS
    Eur J Radiol; 2012 Mar; 81(3):472-7. PubMed ID: 21296517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience.
    Seki A; Hori S; Kobayashi K; Narumiya S
    Cardiovasc Intervent Radiol; 2011 Jun; 34(3):557-65. PubMed ID: 20821211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Image fusion of preprocedural CTA with real-time fluoroscopy to guide proper hepatic artery catheterization during transarterial chemoembolization of hepatocellular carcinoma: a feasibility study.
    Bargellini I; Turini F; Bozzi E; Lauretti D; Cicorelli A; Lunardi A; Cioni R; Bartolozzi C
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):526-30. PubMed ID: 23070106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcatheter arterial chemoembolization through collateral arteries for hepatocellular carcinoma after arterial occlusion.
    Shibata T; Kojima N; Tabuchi T; Itoh K; Konishi J
    Radiat Med; 1998; 16(4):251-6. PubMed ID: 9814419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.
    Kim S; Mannelli L; Hajdu CH; Babb JS; Clark TW; Hecht EM; Taouli B
    J Magn Reson Imaging; 2010 Feb; 31(2):348-55. PubMed ID: 20099348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic release of erythropoietin induced by transarterial chemoembolization in patients with hepatocellular carcinoma.
    Pirisi M; Fabris C; Soardo G; Falleti E; Gasparini D; Vitulli D; Toniutto P; Gonano F; Bartoli E
    Hepatology; 1995 Jul; 22(1):148-52. PubMed ID: 7601407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: a retrospective analysis.
    Katyal S; Oliver JH; Peterson MS; Chang PJ; Baron RL; Carr BI
    AJR Am J Roentgenol; 2000 Dec; 175(6):1665-72. PubMed ID: 11090401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study.
    Caturelli E; Siena DA; Fusilli S; Villani MR; Schiavone G; Nardella M; Balzano S; Florio F
    Radiology; 2000 Apr; 215(1):123-8. PubMed ID: 10751477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Objective assessment of transcatheter arterial chemoembolization angiographic endpoints: preliminary study of quantitative digital subtraction angiography.
    Zhang XB; Zhuang ZG; Ye H; Beilner J; Kowarschik M; Chen JJ; Chi JC; Xu JR
    J Vasc Interv Radiol; 2013 May; 24(5):667-71. PubMed ID: 23489772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective randomized trial of hepatic artery chemotherapy with cisplatin and doxorubicin, with or without lipiodol in the treatment of advanced stage hepatocellular carcinoma.
    Carr BI; Bron K; Swanson DP
    J Clin Gastroenterol; 2011 Oct; 45(9):e87-91. PubMed ID: 21921843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival after transarterial chemoembolization for hepatocellular carcinoma.
    Iozzino M; Spaziani E; Picchio M; Saltarelli A; Di Filippo A; De Angelis F; Narilli F; Stagnitti F; Cianni R
    Clin Ter; 2011; 162(2):129-32. PubMed ID: 21533319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-Dimensional Quantitative Color-Coding Analysis of Hepatic Arterial Flow Change during Chemoembolization of Hepatocellular Carcinoma.
    Lin EY; Lee RC; Guo WY; Wu FC; Gehrisch S; Kowarschik M
    J Vasc Interv Radiol; 2018 Oct; 29(10):1362-1368. PubMed ID: 30170947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.